-
Study aim
-
The aim of the present study is to investigate the effect of weight loss diet based on DASH diet on Pro-Oxidant-Antioxidant Balance (PAB) , lipid profile, liver fibrosis score, appetite status and quality of life among patients with non-alcoholic fatty liver disease.
-
Design
-
Double blind randomized controlled clinical trial
-
Settings and conduct
-
The patients who newly diagnosed as NAFLD and met the inclusion criteria will be included in the study and then randomly assigned into the intervention and control groups.
-
Participants/Inclusion and exclusion criteria
-
44 patients with grade 1 and 2 NAFLD who aged 20-50 years with BMI 30-40 kg / m2 will be included in the study. Those with alcohol consumption, pregnancy, lactation, menopause, being an athlete, having a weight loss diet 3 months before the study, the use of lowering blood sugar, lipid drugs, antibiotics , corticosteroids and antioxidant supplements , suffering from metabolic disease inc. cardiovascular, renal, liver, thyroid, autoimmune diseases, kidney stones and cancers will be excluded.
-
Intervention groups
-
The intervention group will receive a weight loss diet based on the DASH diet while the control group will receive the usual weight loss diet.
-
Main outcome variables
-
Nutritional status (anthropometric indices , and energy and macronutrients intakes), ultrasonography findings, serum levels of Pro-Oxidant-Antioxidant Balance (PAB), lipid profile, liver fibrosis score, appetite status and quality of life